Global law firm White & Case LLP has advised Armira on the acquisition of a 40 percent stake in the PharOS.
"We have advised Armira on this strategic transaction, which is a further testament to our strength in complex, cross-border pharmaceutical transactions," said White & Case partner Marcus Booth, who co-led the Firm's deal team.
Armira is a leading investment company focusing on direct equity investments in medium-sized, family businesses and ambitious growth companies. It acquired the shareholding in PharOS alongside the Viessmann Generations Group.
Founded in 2002 and headquartered in Athens, PharOS has become an international leader in the pharmaceutical industry, with over 470 clients across 115 countries. The company has launched more than 54 products and currently manages over 9,200 marketing authorizations worldwide. The founders and majority owners of PharOS, Stella Koukaki, Theodore Panagopoulos, and Panagiotis Panagopoulos, will retain majority control of the company and remain fully committed to the PharOS' strategic vision.
The White & Case team which advised on the transaction was led by partners Marcus Booth (Dubai, London) and Gareth Eagles (London) and local partner Adnan Bekdur (Dubai) and included partners Assimakis Komninos (Brussels), Daniel Zapf (Frankfurt) and Sara Nordin (Brussels, Stockholm) and associates Thomas Jacques, Charles Tuckwell (both Dubai), James Fox (Abu Dhabi), Iakovos Sarmas (Brussels) and George Croft (London).
Press contact
For more information please speak to your local media contact.
